Indapamide Arrow (Indapamide)

Indapamide inhibits the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This reduces reabsorption of sodium and chloride, leading to increased excretion of water and electrolytes. The resulting decrease in plasma volume, together with a direct vasodilatory effect on peripheral vessels, lowers systemic blood pressure.

The appropriate dose of Indapamide Arrow is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Physicians typically start with a low dose and adjust as needed, following local prescribing guidelines and patient monitoring.

Safety data for Indapamide in pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss alternative options and closely monitor any pregnant or nursing patient who requires treatment.

To place an order, submit an enquiry on the Indapamide Arrow product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class, offering both diuretic and vasodilatory actions. Compared with classic thiazides such as hydrochlorothiazide, it often provides a longer duration of action and may have a lower risk of metabolic side effects. It is commonly used in combination with other antihypertensives for synergistic blood‑pressure control.

Indapamide Arrow should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Keeping the tablets in a dry, tightly closed container helps maintain potency throughout the shelf‑life.

Indapamide Arrow is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional to ensure consistent absorption.

The most serious risks include severe electrolyte disturbances such as hyponatremia or hypokalemia, marked dehydration, and rare allergic reactions that may present as rash, swelling or anaphylaxis. Prompt medical attention is required if any of these severe symptoms develop.

Indapamide Arrow is contraindicated in patients with anuria, severe renal impairment, or known hypersensitivity to indapamide or other thiazide‑like diuretics. Caution is also advised for individuals with severe hepatic disease, gout, or uncontrolled diabetes, and the drug should be avoided unless a physician determines it is appropriate.